Ovulation induction

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 11, 2003, Pages 1995-2004

  Homburg, Roy ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anovulation; Clomiphene citrate; Gonadotropins; Infertility; Low dose gonadotropin therapy; Metformin; Polycystic ovary syndrome; Treatment of anovulation

Indexed keywords

ANASTROZOLE; ANDROGEN; ANTIHYPERTENSIVE AGENT; AROMATASE INHIBITOR; BROMOCRIPTINE; CABERGOLINE; CLOMIFENE CITRATE; DEXAMETHASONE; ESTRADIOL; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; GONADOTROPIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; INSULIN; LETROZOLE; LUTEINIZING HORMONE; METFORMIN; PLACEBO; PRASTERONE SULFATE; PROLACTIN; QUINAGOLIDE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; SEDATIVE AGENT; SEX HORMONE BINDING GLOBULIN; UNINDEXED DRUG;

ADULT; AGE; ANOVULATION; ARTIFICIAL INSEMINATION; BODY WEIGHT DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PURIFICATION; DRUG SAFETY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE DEFICIENCY; HUMAN; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; MULTIPLE PREGNANCY; OBESITY; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; RECOMBINANT DNA TECHNOLOGY; REVIEW; WEIGHT REDUCTION;

ANOVULATION; FEMALE; HUMANS; HYPERPROLACTINEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFERTILITY, FEMALE; OVARIAN FAILURE, PREMATURE; OVULATION; PITUITARY DISEASES;

EID: 0242407440     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.11.1995     Document Type: Review

References (52)

1. WANG JX, DAVIES MJ, NORMAN RJ: Obesity increases the risk of spontaneous abortion during infertility treatment. Obes. Res. (2002) 10:551-554.
2. CROSIGNANI PG, RAGNI G, PARAZZINI F, WYSSLING H, LOMBROSO G, PEROTTI L: Anthropometric indicators and response to gonadotrophin for ovulation induction. Hum. Reprod. (1994) 9:420-423.
3. PORETSKY L, CATALDO NA, ROSENWAKS Z, GIUDICE LC: The insulin related ovarian regulatory system in health and disease. Endoc. Revs. (1999) 20:535-582.
4. DALE O, TANBO T, HAUG E, ABYHOLM T: The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary symdrome. Hum. Reprod. (1998) 13:567-570.
5. HAMILTON-FAIRLEY D, KIDDY D, WATSON H, PATERSON C, FRANKS S: Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary treated with low dose gonadotrophin. Br. J. Obstet. (1992) 99:128-131.
6. WHITE DM, POLSON DW, KIDDY D et al.: Induction of ovulation with low-dose gonadotrophins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J. Clin. Endocrinol. Metab. (1996) 81:3821-3824.
7. CLARK AM, THORNLEY B, TOMLINSON L, GALLETLEY C, NORMAN RJ: Weight loss results in significant improvement in reproductive outcome for all forms of fertility treatment. Hum. Reprod. (1998) 13:1502-1505.
8. KIDDY D, HAMILTON-FAIRLEY D, BUSH A et al.: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (1992) 36:105-111.
9. DICKEY RP, TAYLOR SN, CUROLE DN, RYE PH, LU PY, PYRZAK R: Relationship of clomiphene dose and patient weight to successful treatment. Hum. Reprod. (1997) 12:449-453.
10. GYSLER M, MARCH CM, MISHELL DR, BAILEY EJ: A decade's experience with an individualized clomiphene treatment regimen including its effects on the postcoital test. Fertil. Steril. (1982) 37:161-167.
11. IMANI, B, EIJKEMANS MJ, TE VELDE ER, HABBEMA JD, FAUSER BC: Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. J. Clin. Endocrinol. Metab. (1998) 83:2361-2365.
12. HOMBURG R, ARMAR NA, ESHEL A, ADAMS J, JACOBS HS: Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br. Med. J. (1988) 297:1024-1027.
13. AGRAWAL SK, BUYALOS RP: Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation. Hum. Reprod. (1995) 10:328-331.
14. DALY DC, WALTERS CA, SOTO-ALBORS CE, TOHAN N, RIDDICK DH: A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil. Steril. (1984) 41:844-848.
15. MITWALLY MF, CASPER RF: Use of aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil. Steril. (2001) 75:305-309.
16. MITWALLY MF, CASPER RF: Aromatase inhibition improves ovarian response to FSH: a potential option for low responders during ovarian stimulation. Fertil. Steril. (2001) 75:88-89.
17. HOMBURG R, ESHEL A, ARMAR NA et al.: One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. Br. Med. J. (1989) 298:809-812.
18. BRAAT DD, SCHOEMAKER R, SCHOEMAKER J: Life table analysis of fecundity of intravenously gonadotrophin-releasing hormone treated patients with normogonadotropic and hypogonadotropic amenorrhea. Fertil. Steril. (1991) 55:266-271.
19. THE EUROPEAN AND ISRAELI STUDY GROUP ON HIGHLY PURIFIED MENOTROPIN VERSUS RECOMBINANT FOLLICLE-STIMULATING HORMONE: Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fetilization/ intracytoplasmic sperm injection cycles: a randomized, comparative trial. Fertil. Steril. (2002) 78:520-528.
20. BALEN A: Bye-bye urinary gonadotrophins? Is there a risk of prion disease after administration of urinary-derived gonadotrophins? Hum. Reprod. (2002) 17:1676-1680.
21. EUROPEAN PHARMACOPEIA: 4th edn (2002):2101-2103.
22. DRIEBERGEN R, BAER G: Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age? Curr. Med. Res. Opin. (2003) 19:41-46.
23. YARALI H, BUKULMEZ O, GURGAN T: Urinary follicle stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogunaotrophic, chronic anovulation: a prospective randomized study. Fertil. Steril. (1999) 72:276-281.
24. BAYRAM N, VAN WELY M, VAN DER VEEN F: Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. The Cochrane Library (2002) Issue 1:Oxford Update Software.
25. HUGHES E, COLLINS J, VANDEKERCKHOVE P: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotrophin for clomiphene resistant polycystic ovary syndrome. The Cochrane Library (1996) Issue 3:Oxford Update Software.
26. THE EUROPEAN RECOMBINANT HUMAN LH STUDY GROUP: Recombinant human luteinizing hormone (LH) to support human follicle-stimulating hormone (FSH)-induced follicular development in LH and FSH deficient anovulatory women: a dose-finding study. J. Clin. Endocrinol. Metab. (1998) 83:1507-1514.
27. LOUMAYE L, ENGRAND P, SHOHAM Z, HILLIER S, BAIRD D: Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in WHO Type I and Type II anovulation. Hum. Reprod (2003) 18:314-322.
28. HAMILTON-FAIRLEY D, FRANKS S: Common problems in induction of ovulation. Balliere Clin. Obstet. Gynaecol. (1990) 4:609-625.
29. VAN DER MEER M, HOMPES P, DE BOER J, SCHATS R, SCHOEMAKER J: Cohort size rather than follicle-stimulating hormone threshold levels determines ovarian sensitivity in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. (1988) 83:423-426.
30. POLSON, DW, MASON, HD, SALDAHNA MBY, FRANKS, S: Ovulation of a single dominant follicle during treatment with low-dose pulsatile FSH in women with PCOS. Clin. Endocrinol. (1987) 26:205-212.
31. HOMBURG R, HOWLES CM: Low dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, reflections and refinements. Hum. Reprod. Update (1999) 5:493-499.
32. VAN SANTBRINK EJP, FAUSER BCJM: Urinary follicle-stimulating hormone for normogonadotropic clomiphene resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J. Clin. Endocrinol. Metab. (1997) 82:3597-3602.
33. CHRISTIN-MAITRE S, HUGUES JN: A comparative randomized multricentric study comparing the step-up versus the step-down protocol in polycystic ovary syndrome. Hum. Reprod. (In Press).
34. HOMBURG R: Adverse effect of luteinizing hormone on fertility: fact or fantasy. Bailliere's Clin. Obstet. Gynaecol.(1996) 12:555.
35. HOMBURG R, LEVY T, BERKOVITZ D: GnRH agonist reduces the miscarriage rate for pregnancies conceived in women with polycystic ovary syndrome. Fertil. Steril. (1993) 59:527-531.
36. LANZONE A, FULGHESU AM, VILLA P et al.: Gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin as a trigger of ovulation in polycystic ovarian disease gonadotrophin hyperstimulated cycles. Fertil. Steril. (1994) 62:35-41.
37. EGBASE PE, GRUDZINSKAS JG, AL SHARHAN M et al.: HCG or GnRH agonist to trigger ovulation in GnRH antagonist - treated intrauterine insemination cycles: a prospective randomized study. Hum. Reprod. (2002) 17:2 (Abstract).
38. ELKIND-HIRSCH KE, WEBSTER BW, BROWN CP, VERNON MW: Concurrent ganirelix and follitropin - beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome. Fertil. Steril. (2003) 79:603-607.
39. FLEMING R, HOPKINSON ZE, WALLACE AM, GREER IA, SATTAR N: Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J. Clin. Endocrinol. Metab. (2002) 87:569-574.
40. NESTLER JE, STOVALL D, AKHTERN, IUORNO MJ, JACUBWICZ DJ: Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil. Steril. (2002) 77:209-215.
41. VELAZQUEZ EM, ACOSTA A, MENDOZA SG: Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet. Gynecol. (1997) 90:392-395.
42. MOGHETTI P, CASTELLO R, NEGRI C et al.: Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J. Clin. Endocrinol. Metab. (2000) 85:139-146.
43. COSTELLO MF, EDEN JA. A systemic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil. Steril. (2003) 79:1-13.
44. VANDERMOLEN DT, RATTS VS, EVANS WS et al.: Metformin increases the ovulatory rate and pregnancy rate with clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil. Steril. (2001) 75:310-315.
45. NESTLER JE, JAKUBOWICZ DJ, EVANS WS, PASQUALI R: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N. Engl. J. Med. (1998) 338:1876-1880.
46. GEORGE SS, GEORGE K, IRWIN C et al.: Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomised, controlled trial. Hum. Reprod. (2003) 18:299-304.
47. DE LEO V, LA MARCA A, DITTO A et al.: Effects of metformin on gonadotropin-induced ovulation women with polycystic ovary syndrome. Fertil. Steril. (1999) 72:282-285.
48. YARALI H, YILDIZ BO, DEMIROL A et al.: Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized trial. Hum. Reprod. (2002) 17:289-294.
49. HOMBURG R: Should patients with polycystic ovary syndrome be treated with metformin? Hum. Reprod. (2002) 17:853-856.
50. GLUECK CJ, WANG P, GOLDENBERG N, SIEVE-SMITH L: Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum. Reprod. (2002) 17:2858-2864.
51. PLATTEAU P, LAURENT E, ALBANO C et al.: An open, randomized single-centre study to compare the efficacy and convenience of follitropin-beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. Hum. Reprod. (2003) 18:1200-1204.
52. BECKERS MG, MACKLON NS, DEVROEY P, PLATTEAU P, EORRIGTER PJ, FAUSER BC: First pregnancy after ovarian stimulation using a chimeric long-acting human recombinant FSH agonist (rFSH-CTP) for in vitro fertilization. Fertil. Steril. (2003) 79:621-623.